Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis

Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis

Background: Serum fibrosis markers for systemic sclerosis (SSc) remain limited. The Enhanced Liver Fibrosis (ELF) score is a collagen marker set consisting of procollagen type III amino terminal propeptide (PIIINP), tissue inhibitor of metalloproteinases 1 (TIMP-1), and hyaluronic acid (HA). This lo...

Full description

Bibliographic Details
Main Authors:	Chen Chen, Lingbiao Wang, Jinfeng Wu, Meijuan Lu, Sen Yang, Wenjing Ye, Ming Guan, Minrui Liang, Hejian Zou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Series:	Frontiers in Pharmacology
Subjects:	enhanced liver fibrosis (ELF) score hyaluronic acid modified rodnan skin score (mRSS) procollagen type iii aminoterminal propeptide systemic sclerosis (SSc) tissue inhibitor for metalloproteinase (TIMP)
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.805708/full

Similar Items

Correlation Between Skin and Affected Organs in 52 Sclerodermic Patients Followed in a Diseases Management Team: Development of a Risk Prediction Model of Organ-Specific Complications
by: Emanuele Cozzani, et al.
Published: (2021-06-01)

Inflammation and Fibrosis in Sleep-Disordered Breathing after Acute Myocardial Infarction
by: Jan Pec, et al.
Published: (2024-01-01)

Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
by: Patrick-Pascal Strunz, et al.
Published: (2021-09-01)

A Double-blind, Randomized Controlled Trial of Ciplukan (Physalis angulata Linn) Extract on Skin Fibrosis, Inflammatory, Immunology, and Fibrosis Biomarkers in Scleroderma Patients
by: Sumartini Dewi, et al.
Published: (2019-10-01)

Association between P1NP and bone strength in postmenopausal women treated with teriparatide
by: Fang-Ping Chen, et al.
Published: (2022-01-01)

Trends in systemic inflammatory factors and aminoterminal brain natriuretic propeptide in the treatment of chronic heart failure
by: Elena Nikolaevna Egorova, et al.
Published: (2011-01-01)

Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy
by: Patrício Aguiar, et al.
Published: (2018-03-01)

Predictive Value of Collagen Biomarkers in Advanced Chronic Kidney Disease Patients
by: Carina Ureche, et al.
Published: (2023-02-01)

Elastography as a possible useful method of assessment of skin involvement in systemic sclerosis
by: Piotr Sobolewski, et al.
Published: (2021-10-01)

How to perform high ultrasound examination of skin involvement among patients with systemic sclerosis – proposition of a unified protocol
by: Piotr Sobolewski, et al.
Published: (2021-02-01)

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms
by: Hans Carl Hasselbalch, et al.
Published: (2023-08-01)

Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients
by: Carina Ureche, et al.
Published: (2023-04-01)

Serum level of N-terminal propeptide of type I procollagen in people of various ages and gender
by: V.V. Povoroznyuk, et al.
Published: (2020-02-01)

Involvement of bone-specific alkaline phosphatase and procollagen I carboxy-terminal propeptide as predictors of early fracture risk in Chinese Children with juvenile osteoporosis: An interventional clinical trial
by: Yu Wang, et al.
Published: (2018-05-01)

Training Course Results of the Assessment of Modified Rodnan Skin Score in Scleroderma
by: Gerçek CAN, et al.
Published: (2022-03-01)

The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
by: Elma Kučukalić-Selimović, et al.
Published: (2013-11-01)

Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation
by: Yamamoto T, et al.
Published: (2015-07-01)

Rituximab for the therapy of systemic sclerosis: a series of 10 cases in a single center
by: Verônica Silva Vilela, et al.

Clinical significance of interleukin 27 serum concentration in patients with systemic sclerosis: relation to clinical, laboratory and radiological parameters
by: Waleed A Hassan, et al.
Published: (2019-01-01)

Ciclofosfamida: eficaz no tratamento do quadro cutâneo grave da esclerose sistêmica Cyclophosphamide: effective in the treatment of severe cutaneous involvement in systemic sclerosis
by: Patrícia Andrade de Macedo, et al.
Published: (2009-06-01)

Correlation between Interstitial Lung Disease Morphology Scores Based on High-resolution Computed Tomography Chest and Skin Fibrosis Degree Based on Modified Rodnan’s Skin Score on Systemic Sclerosis
by: Irma Hassan Hikmat, et al.
Published: (2021-07-01)

Correlation between Serum Interleukin-6 Level and Modified Rodnan Skin Score in Systemic Sclerosis Patients
by: Dania Artriana Riswandi, et al.
Published: (2021-10-01)

Durometry as an alternative tool to the modified Rodnan’s skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study
by: Marília de Fátima Cirioli de Oliveira, et al.
Published: (2020-09-01)

ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
by: Ian Y. Luk, et al.
Published: (2018-08-01)

The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo
by: Fiona H. X. Guan, et al.
Published: (2017-03-01)

Impact of liver fibrosis and nodules formation on hemodynamics in young adults after total cavopulmonary connection. A magnetic resonance study
by: Václav Chaloupecký, et al.
Published: (2022-09-01)

Efficacy and safety of rituximab in treatment of systemic sclerosis: A retrospective study
by: Anupama Singh, et al.
Published: (2023-01-01)

Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis
by: Emmanuel Ledoult, et al.
Published: (2020-02-01)

High-throughput quantitative histology in systemic sclerosis skin disease using computer vision
by: Chase Correia, et al.
Published: (2020-03-01)

ELF pedagogy and awareness: an action research applied to Italian tertiary students in ELF Skype interactions
by: Antonio Taglialatela, et al.
Published: (2020-09-01)

Intra-Individual Changes in Total Procollagen-Type 1 N-terminal Propeptide in a Korean Adult Population
by: Rihwa Choi, et al.
Published: (2022-10-01)

Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis
by: Mitsuru Furukawa, et al.
Published: (2022-09-01)

Mediating linguacultural asymmetries through ELF in unequal immigration encounters
by: Maria Grazia Guido
Published: (2016-01-01)

THAI UNIVERSITY STUDENTS’ ATTITUDES TOWARDS ELF IN CLASSROOM CONTEXTS: A MIXED-METHODS STUDY
by: Sumit Choemue, et al.
Published: (2021-06-01)

The Levels of Serum Serotonin Can Be Related to Skin and Pulmonary Manifestations of Systemic Sclerosis
by: Marin Petrić, et al.
Published: (2022-01-01)

A study on extreme low frequency (ELF) electromagnetic effects /
by: Zulkurnain Abd. Malek, et al.
Published: (2007)

ELF Electromagnetic Waves from Lightning: The Schumann Resonances
by: Colin Price
Published: (2016-09-01)

Cohesion as interaction in ELF spoken discourse
by: T. Christiansen
Published: (2013-10-01)

Fragmented QRS complexes are a marker of myocardial fibrosis in hypertensive heart disease
by: Lütfü Bekar, et al.
Published: (2016-10-01)

Lucilla Lopriore and Enrico Grazzi (eds.), Intercultural Communication. New Perspectives from ELF
by: Julia Boyd
Published: (2016-12-01)